Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

304
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
304
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

341
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
341
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

434
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
434
An Overview of Psychoactive Drugs01:28

An Overview of Psychoactive Drugs

353
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
353
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

424
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
424
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

824
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
824

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Board-certified psychiatric pharmacists in substance use disorder treatment: Integration, services, and outcomes across care settings.

The mental health clinician·2026
Same author

The Role of Board-Certified Psychiatric Pharmacists in Substance Use Disorder Care.

Substance use & addiction journal·2025
Same author

Managing ciprofloxacin-clozapine interaction with immunoassay-based monitoring: A case report.

The mental health clinician·2025
Same author

Standard Instructions and Counseling for Naloxone Insufficient in the Era of Xylazine and Medetomidine Adulteration of Illicit Opioids.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians·2025
Same author

Impact of weight loss surgery on valproic acid levels: A case report.

The mental health clinician·2025
Same author

Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review.

Addiction science & clinical practice·2025

Related Experiment Video

Updated: Oct 24, 2025

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.4K

Pharmacologic Similarities and Differences Among Hallucinogens.

Kristin Waters1

  • 1School of Pharmacy, University of Connecticut, Storrs, Connecticut, USA.

Journal of Clinical Pharmacology
|August 16, 2021
PubMed
Summary

This review compares hallucinogenic substances, detailing their diverse mechanisms of action beyond classical serotonergic pathways. It examines their pharmacological profiles and associated physical and psychiatric effects, including potential toxicities.

Keywords:
hallucinogenillicit drugspsychedelicsubstance use disorderstryptamines

More Related Videos

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
11:14

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Published on: October 2, 2016

11.8K
Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

25.6K

Related Experiment Videos

Last Updated: Oct 24, 2025

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.4K
Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
11:14

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Published on: October 2, 2016

11.8K
Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

25.6K

Area of Science:

  • Pharmacology
  • Neuroscience
  • Toxicology

Background:

  • Hallucinogens alter thoughts, perceptions, and mood via various mechanisms.
  • Classical hallucinogens primarily act on serotonergic pathways (e.g., LSD, psilocybin).
  • Other hallucinogens engage diverse targets like NMDA receptors, opioid receptors, and monoamine transporters.

Purpose of the Study:

  • To compare pharmacologic similarities and differences among hallucinogenic substances.
  • To analyze the impact of these substances on physical and psychiatric effects.
  • To review potential acute and long-term toxicities associated with hallucinogen use.

Main Methods:

  • Comparative pharmacologic analysis.
  • Review of existing literature on hallucinogen mechanisms and effects.
  • Toxicology assessment of various hallucinogenic compounds.

Main Results:

  • Hallucinogens exhibit diverse mechanisms beyond serotonin.
  • Pharmacologic actions correlate with distinct physical and psychiatric outcomes.
  • Specific hallucinogens present unique toxicity profiles, including severe and chronic risks.

Conclusions:

  • Understanding diverse hallucinogen pharmacology is crucial for predicting effects and risks.
  • Comprehensive review highlights the varied impact of hallucinogens on user health.
  • Further research is needed to fully elucidate the long-term toxicities and therapeutic potentials.